Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines

Leukemia Research

Volumn 32, Issue 5, 2008, Pages 791-797

  Cecchinato, V ^a   Erba, E ^c   Basile, A ^a   Scarpati, B ^b   Fazi, C ^b   Brando, B ^b   Comi, P ^a   Chiaramonte, R ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Apoptosis; Bax; Bcl 2; Cell cycle; HMBA; Notch1; p53; T ALL

Indexed keywords

HEXAMETHYLENEBISACETAMIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE; CELL CYCLE PROGRESSION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACETAMIDES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 4; GAMMA-AMINOBUTYRIC ACID; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION; TRIGLYCERIDES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 40049102123     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.09.008     Document Type: Article

References (16)

1. Marks P.A., Richon V.M., Kiyokawa H., and Rifkind R.A. Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process. Proc Natl Acad Sci USA 91 (1994) 10251-10254
2. Andreeff M., Stone R., Michaeli J., Young C.W., Tong W., Sogoloff H., et al. Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent. Blood 80 (1992) 2604-2609
3. Marks P.A., Richon V.M., Breslow R., and Rifkind R.A. Hybrid polar inducers of transformed cell differentiation/apoptosis. From the cell to the clinic. CR Acad Sci III 322 (1999) 161-165
4. Richon V.M., Ramsay R.G., Rifkind R.A., and Marks P.A. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation. Oncogene 4 (1989) 165-173
5. Siegel D.S., Zhang X., Feinman R., Teitz T., Zelenetz A., Richon V.M., et al. Hexamethylene bisacetamide induces programmed cell death (apoptosis) and down-regulates Bcl-2 expression in human myeloma cells. Proc Natl Acad Sci USA 95 (1998) 162-166
6. Shelly L.L., Fuchs C., and Miele L. Notch-1 inhibits apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar compounds. J Cell Biochem 73 (1999) 164-175
7. Ellisen L.W., Bird J., West D.C., Soreng A.L., Reynolds T.C., Smith S.D., et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66 (1991) 649-661
8. Weng A.P., Ferrando A.A., Lee W., Morris IV J.P., Silverman L.B., Sanchez-Irizarry C., et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306 (2004) 269-271
9. Chiaramonte R., Calzavara E., Balordi F., Sabbadini M., Capello D., Gaidano G., et al. Differential regulation of Notch signal transduction in leukemia and lymphoma cells in culture. J Cell Biochem 88 (2003) 569-577
10. Chiaramonte R., Basile A., Tassi E., Calzavara E., Cecchinato V., Rossi V., et al. A wide role for NOTCH1 signaling in acute leukemia. Cancer Lett 219 (2005) 113-120
11. Deftos M.L., He Y.W., Ojala E.W., and Bevan M.J. Correlating Notch signaling with thymocyte maturation. Immunity 9 (1998) 777-786
12. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
13. Erba E., Bergamaschi D., Bassano L., Damia G., Ronzoni S., Faircloth G.T., et al. Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action. Eur J Cancer 37 (2001) 97-105
14. Sharma V.M., Calvo J.A., Draheim K.M., Cunningham L.A., Hermance N., Beverly L., et al. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc. Mol Cell Biol 26 (2006) 8022-8031
15. Shieh S.Y., Ikeda M., Taya Y., and Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91 (1997) 325-334
16. Terada M., Nudel U., Fibach E., Rifkind R.A., and Marks P.A. Changes in DNA associated with induction of erythroid differentiation by dimethyl sulfoxide in murine erythroleukemia cells. Cancer Res 38 (1978) 835-840